Abstract
Antimicrobial resistance among common respiratory pathogens has become a significant problem. However, there remain multiple treatment options, including the newer macrolides, third-generation cephalosporins, beta-lactam/beta-lactamase inhibitor antibiotics, and the newer fluoroquinolones.
MeSH terms
-
Community-Acquired Infections / epidemiology
-
Community-Acquired Infections / microbiology*
-
Community-Acquired Infections / prevention & control
-
Drug Resistance, Microbial*
-
Europe / epidemiology
-
Haemophilus influenzae / drug effects
-
Humans
-
Moraxella catarrhalis / drug effects
-
Respiratory Tract Infections / epidemiology
-
Respiratory Tract Infections / microbiology*
-
Respiratory Tract Infections / prevention & control
-
Staphylococcus aureus / drug effects
-
Streptococcus pneumoniae / drug effects
-
United States / epidemiology